Not a good buy right now: the stock is trading well above recent Wall Street price targets ($61–$65), while analyst sentiment has deteriorated (two downgrades in the last ~2 months).
Technicals are bullish but slightly stretched (RSI 65) and upside is capped near resistance (85.35) unless earnings materially surprise.
Options positioning is mixed (heavy put open interest but call-heavy volume), which does not confirm a clean risk-on setup.
Net: avoid initiating a new position at 82.3; only consider if it pulls back toward support (~78.6) or after the 2026-02-19 earnings catalyst clarifies the outlook.
Technical Analysis
Trend: Bullish structure with SMA_5 > SMA_20 > SMA_200, implying a continuing uptrend.
Momentum: MACD histogram positive (0.152) but contracting, suggesting upside momentum is fading rather than accelerating.
RSI(6)=65.14: near the upper end of neutral (not overbought, but getting crowded), reducing the reward/risk for an impatient entry.
Key levels: Pivot 81.99 (price 82.3 is just above it). Resistance R1 85.35 then R2 87.43. Support S1 78.62 then S2 76.54.
Pattern-based probability (similar candlesticks): next week modestly positive (+2.57%), but next month biased negative (-4.63%), aligning with “near-term ok, medium-term risk.”
Options Data
Bearish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio
Open interest Put/Call = 2.12: positioning skews defensive/hedged (more puts outstanding than calls), often seen when investors are cautious.
Volume Put/Call = 0.2 (calls dominate today’s flow): short-term trading sentiment is more bullish, but total volume is very low (24 contracts), so the signal is weak.
IV: 30D IV ~32.67 vs HV ~29.67; IV percentile 36 / IV rank ~10 suggests options are not expensive—no strong “fear premium,” but also not screaming complacency.
Net income: 286,043,387.86 (+45.83% YoY) — strong profitability acceleration.
EPS: 0.56 (+180.00% YoY) — very strong per-share growth (likely aided by operating leverage and/or base effects).
Overall: fundamentals are improving, but the market/analyst narrative is focused on 2026 headwinds and risk-reward balance rather than backward-looking growth.
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
Recent direction: turning more bearish.
2026-01-21 (Citi): Downgraded to Neutral from Buy; PT COP 70,000; cited more balanced risk-reward and 2026 bank surcharge offsetting NIM tailwinds.
2025-12-17 (Santander): Downgraded to Underperform from Neutral; PT $61.
2025-11-21 (JPMorgan): Kept Neutral; raised PT to $65 (from $48).
Wall Street pro view (pros): NIM expansion potential in a hawkish cycle; strong recent earnings momentum.
Wall Street pro view (cons): 2026 surcharge/regulatory burden and risk-reward no longer compelling at current levels (targets below spot).
Wall Street analysts forecast CIB stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for CIB is 59.33 USD with a low forecast of 52 USD and a high forecast of 65 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
4 Analyst Rating
Wall Street analysts forecast CIB stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for CIB is 59.33 USD with a low forecast of 52 USD and a high forecast of 65 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
0 Buy
2 Hold
2 Sell
Moderate Sell
Current: 76.310
Low
52
Averages
59.33
High
65
Current: 76.310
Low
52
Averages
59.33
High
65
Citi
Brian Flores
Buy -> Neutral
downgrade
$70,000
AI Analysis
2026-01-21
Reason
Citi
Brian Flores
Price Target
$70,000
AI Analysis
2026-01-21
downgrade
Buy -> Neutral
Reason
Citi analyst Brian Flores downgraded Grupo Cibest to Neutral from Buy with a COP 70,000 price target as part of a broader research note previewing Q4 for Colombia diversified banks. The firm sees a "more balanced" risk-reward environment in Colombia, with higher wages spurring a hawkish monetary cycle that supports net interest margin expansion being balanced by the recently approved emergency degree that brought a 15-percentage-point surcharge for banks in 2026, the analyst tells investors in a research note.
Grupo Santander
Andres Soto
Neutral -> Underperform
downgrade
$61
2025-12-17
Reason
Grupo Santander
Andres Soto
Price Target
$61
2025-12-17
downgrade
Neutral -> Underperform
Reason
Grupo Santander analyst Andres Soto downgraded Grupo Cibest to Underperform from Neutral with a $61 price target.
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for CIB
